Cargando…
Identifying the Effect of COVID-19 Infection in Multiple Myeloma and Diffuse Large B-Cell Lymphoma Patients Using Bioinformatics and System Biology
The severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), also referred to as COVID-19, has spread to several countries and caused a serious threat to human health worldwide. Patients with confirmed COVID-19 infection spread the disease rapidly throughout the region. Multiple myeloma (M...
Autores principales: | Li, Chengcheng, Zhang, Ying, Xiao, Yingying, Luo, Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9711963/ https://www.ncbi.nlm.nih.gov/pubmed/36466549 http://dx.doi.org/10.1155/2022/7017317 |
Ejemplares similares
-
A bendamustine resistance gene signature in diffuse large B-cell lymphoma and multiple myeloma
por: Issa, Issa Ismail, et al.
Publicado: (2021) -
Vagal Nerve Activity Predicts Prognosis in Diffused Large B-Cell Lymphoma and Multiple Myeloma
por: Atar, Or, et al.
Publicado: (2023) -
Developing high-affinity decoy receptors to treat multiple myeloma and diffuse large B cell lymphoma
por: Miao, Yu Rebecca, et al.
Publicado: (2022) -
Novel bioinformatic classification system for genetic signatures identification in diffuse large B-cell lymphoma
por: Zhang, Wei, et al.
Publicado: (2020) -
A bioinformatics perspective on molecular classification of diffuse large B-cell lymphoma
por: Mendeville, Matias, et al.
Publicado: (2022)